Trial start date

Nov 27, 2023
1 min read

Updated: Jan 11, 2024

Today, we officially kick off the REDUSE trial (NCT06140147)!

The REDUSE trial aims to learn whether restricting the administration of fluids improves outcomes compared to usual care in patients with septic shock.

For more information about the trial, please visit the Clinical Trials homepage https://clinicaltrials.gov/study/NCT06140147 or read about the trial on our website.

Recent Posts

See All

REDUSE hits 50% of patient recruitment target

(June 15) Last month, the REDUSE trial passed a significant milestone by reaching 50% of its target for patient inclusion. This major threshold is an exciting development, as it reflects the interest

Patient recruitment for REDUSE begins in Tampere, Finland

(May 25) Tammerfors University Hospital (Tays) in Tampere, Finland, became the second international site to commence patient recruitment for the REDUSE study. This exciting development comes just seve

Thesis defended by another REDUSE team member, Linn Hemberg

(March 31) Linn Hemberg, an environmental science researcher in perioperative and intensive care, defended her thesis, "Critical Care, Critical Emissions: Applying life cycle assessment on intensive a

Comments